EyePoint EYPT
NASDAQ EYPT
$4.58 +0.01 (+0.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

EyePoint (EYPT) Other Accumulated Expenses (2012 - 2026)

EyePoint (EYPT) posted Other Accumulated Expenses of $701000.0 for Q1 2026, down 67.24% sequentially from $2.1 million in Q4 2025, and down 64.33% YoY from $2.0 million in Q1 2025.

Analysis

EyePoint (EYPT) Other Accumulated Expenses (2012 - 2026) Analysis & Trends

EyePoint has reported Other Accumulated Expenses for 15 years, with the latest figure at $701000.0 in Q1 2026.

  • Quarterly Other Accumulated Expenses fell 64.33% year-over-year to $701000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $701000.0 (down 64.33% YoY) and the FY2025 annual result came in at $2.1 million, up 48.61% from the prior year.
  • Other Accumulated Expenses eased to $701000.0 in Q1 2026 per EYPT's latest filing, from $2.1 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $2.1 million in Q4 2025 and troughed at $183000.0 in Q3 2023.
  • A 5-year average of $882529.4 and a median of $753000.0 in 2025 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses tumbled 74.73% in 2023, then surged 761.84% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $1.8 million in 2022, then tumbled by 63.25% to $646000.0 in 2023, then soared by 122.91% to $1.4 million in 2024, then surged by 48.61% to $2.1 million in 2025, then sank by 67.24% to $701000.0 in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $701000.0, $2.1 million, and $434000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 EyePoint 398.53 Mn 218.06 Mn 507,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.68 Mn
Mar 31, 2026 2.21 Mn
Dec 31, 2025 2.14 Mn
Sep 30, 2025 2.08 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 1.97 Mn
Dec 31, 2024 1.44 Mn
Sep 30, 2024 1.29 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.18 Mn
Dec 31, 2023 646,000.00
Sep 30, 2023 1.06 Mn
Jun 30, 2023 970,000.00
Mar 31, 2023 884,000.00
Dec 31, 2022 1.76 Mn
Sep 30, 2022 1.08 Mn
Jun 30, 2022 926,000.00
Mar 31, 2022 1.15 Mn
Dec 31, 2021 1.14 Mn
Sep 30, 2021 1.41 Mn